🇪🇺 Fibrin Sealant 2 (FS2) in European Union

EMA authorised Fibrin Sealant 2 (FS2) on 5 October 2008

Marketing authorisation

EMA — authorised 5 October 2008

  • Application: EMEA/H/C/000898
  • Marketing authorisation holder: Omrix Biopharmaceuticals N. V.
  • Local brand name: Evicel
  • Indication: Evicel is used as supportive treatment in surgery where standard surgical techniques are insufficient, for improvement of haemostasis. Evicel is also indicated as suture support for haemostasis in vascular surgery.
  • Status: withdrawn

Read official source →

Other Surgery / Hemostasis approved in European Union

Frequently asked questions

Is Fibrin Sealant 2 (FS2) approved in European Union?

Yes. EMA authorised it on 5 October 2008.

Who is the marketing authorisation holder for Fibrin Sealant 2 (FS2) in European Union?

Omrix Biopharmaceuticals N. V. holds the EU marketing authorisation.